Prestige Brand Holdings Stock Earnings Reports

Prestige reported Q1 fiscal 2026 revenue of $249.5M, down ~6.6% YoY, missing the prior quarter outlook primarily due to an extended production shutdown at its Clear Eyes supplier which caused significant supply shortfalls. Gross margin expanded ~150 bps to 56.2%, helping adjusted diluted EPS of $0.95 (up ~6% vs. adjusted prior year) despite the sales miss. Free cash flow was a record $78M in Q1 and the company reaffirmed a full-year FCF target of $245M+. Management announced an agreement to acquire Pillar5 (a primary Clear Eyes contract manufacturer) for ~ $100M in cash to secure and expand sterile eye-care capacity; they expect some supply improvement late in Q2 with a more meaningful recovery in H2 FY26 and into FY27. Guidance was updated: FY26 revenue of $1.100B–$1.115B (organic decline ~1.5%–3%), Q2 revenue ~$256M–$259M, and adjusted EPS now expected $4.50–$4.58 (roughly flat to +1% vs. prior year). International grew ~7% in Q1 and e‑commerce consumption trends remain strong (double-digit). Tariff exposure was revised down to an estimated $5M for the year, capex guidance modestly increased to 1%–3% of sales (from 1%–2%), and management repurchased ~400k shares for $35M in the quarter while maintaining leverage (~2.4x net debt). Overall, investors should focus on: (1) the Pillar5 acquisition as the company’s primary corrective action to address Clear Eyes supply and long-term capacity needs; (2) the expectation that supply-driven revenue weakness will be concentrated in H1 with recovery materializing in H2 and into FY27; (3) margin resiliency and strong cash generation that support continued capital deployment (M&A, buybacks, debt reduction).